CurrentRheuma
Get Weekly

Topic · page 11 of 17

Systemic sclerosis & Raynaud's

Limited and diffuse systemic sclerosis, skin, lung (interstitial lung disease), pulmonary arterial hypertension, heart, gut and kidney involvement in systemic sclerosis, digital ulcers, primary and secondary Raynaud's phenomenon, very early systemic sclerosis

Briefs 401–440 of 671 placed here, newest publication first

Briefs in Systemic sclerosis & Raynaud's

Newest publication first

  1. Clin Exp Rheumatol

    Ultrasound for day-to-day clinical use: construction of a simple discriminator between healthy skin and thickened systemic sclerosis skin

    Cross-sectional study

  2. Semin Arthritis Rheum

    Whole phenotype of patients with systemic sclerosis and sicca manifestations: Comparison with sicca manifestations from other causes

    Cross-sectional study

  3. J Rheumatol

    Systemic Sclerosis Sine Scleroderma: A Time of Reappraisal

    Meta-analysis

  4. Arthritis Res Ther

    The impact of gastroesophageal reflux disease and its treatment on interstitial lung disease outcomes

    Cohort study

  5. Scand J Rheumatol

    Bicaudal D2 autoantibodies are highly specific for systemic sclerosis

    Cross-sectional study

  6. Semin Arthritis Rheum

    Role of intravenous immunoglobulins in systemic sclerosis (SSc): A systematic literature review

    Research article

  7. J Rheumatol

    Long-Term Data on Efficacy and Safety of Selexipag for Digital Systemic Sclerosis Vasculopathy

    Cohort study

  8. Clin Exp Rheumatol

    Mapping in healthy subjects different body areas for dermal thickness and skin hardness by high frequency ultrasound and durometry

    Cross-sectional study

  9. J Rheumatol

    Effects of Radiotherapy for Malignancy in Systemic Sclerosis: A Systematic Review

    Meta-analysis

  10. Arthritis Care Res (Hoboken)

    Peer‐Led Symptom Management Intervention to Enhance Resilience in People With Systemic Sclerosis: Mediation Analysis From a Randomized Clinical Trial

    Secondary analysis

  11. RMD Open

    Dysregulation of circulating collagen turnover markers in very early systemic sclerosis

    Cross-sectional study

  12. Arthritis Res Ther

    Dystrophic calcinosis: structural and morphological composition, and evaluation of ethylenediaminetetraacetic acid (‘EDTA’) for potential local treatment

    Mechanistic study

  13. Semin Arthritis Rheum

    Polypharmacy, drug-drug interactions, and adverse drug reactions among systemic sclerosis patients: A cross-sectional risk factor study.

    Cross-sectional study

  14. Semin Arthritis Rheum

    Assessing the quality of forced vital capacity measurement in patients with systemic sclerosis

    Cross-sectional study

  15. RMD Open

    Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort

    Cohort study

  16. Rheumatology (Oxford)

    Native myocardial T1 and right ventricular size by CMR predict outcome in systemic sclerosis-associated pulmonary hypertension

    Cohort study

  17. Rheumatology (Oxford)

    Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study

    Cohort study

  18. Arthritis Care Res (Hoboken)

    Quantifying the Need for Specialist Palliative Care Management in Patients With Systemic Sclerosis

    Cohort study

  19. Scand J Rheumatol

    Causes and predictors of death among Finnish patients with systemic sclerosis

    Cohort study

  20. Semin Arthritis Rheum

    COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study

    Cohort study

  21. Rheumatology (Oxford)

    Arthritis in patients with very early systemic sclerosis: a comprehensive clinical and prognostic analysis

    Cohort study

  22. Arthritis Rheumatol

    Outcomes of Patients With Diffuse Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation Treated With Conventional Therapy

    Cohort study

  23. Arthritis Care Res (Hoboken)

    Serum CCL24 as a Biomarker of Fibrotic and Vascular Disease Severity in Systemic Sclerosis

    Cohort study

  24. Semin Arthritis Rheum

    Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis

    Cohort study

  25. Arthritis Res Ther

    Clinical features of patients with systemic sclerosis positive for anti-SS-A antibody: a cohort study of 156 patients

    Cohort study

  26. Arthritis Rheumatol

    Myeloablation Followed by Hematopoietic Stem Cell Transplantation and Long‐Term Normalization of Systemic Sclerosis Molecular Signatures

    Secondary analysis

  27. Rheumatology (Oxford)

    Brentuximab vedotin for skin involvement in refractory diffuse cutaneous systemic sclerosis, an open-label trial

    Research article

  28. Arthritis Care Res (Hoboken)

    Evaluation of the European Society of Cardiology Risk Assessment Score in Incident Systemic Sclerosis‐Associated Pulmonary Arterial Hypertension

    Diagnostic or prognostic study

  29. Semin Arthritis Rheum

    Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis

    Cohort study

  30. RMD Open

    Induction of regulatory T cells and efficacy of low-dose interleukin-2 in systemic sclerosis: interventional open-label phase 1–phase 2a study

    Research article

  31. Scand J Rheumatol

    Comparing the safety and efficacy of nintedanib starting dose in patients with connective tissue disease-associated interstitial lung diseases

    Cohort study

  32. Arthritis Rheumatol

    Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines

    Secondary analysis

  33. Rheumatology (Oxford)

    Systemic sclerosis-associated pulmonary arterial hypertension is characterized by a distinct peripheral T helper cell profile

    Cross-sectional study

  34. Rheumatology (Oxford)

    Efficacy of methylprednisolone in very early systemic sclerosis: results of the ‘Hit Hard and Early’ randomized controlled trial

    Randomized controlled trial

  35. Rheumatology (Oxford)

    Frequency and implications of malnutrition in systemic sclerosis

    Cohort study

  36. Rheumatology (Oxford)

    Capi-score: a quantitative algorithm for identifying disease patterns in nailfold videocapillaroscopy

    Diagnostic or prognostic study

  37. Arthritis Care Res (Hoboken)

    A Prospective Observational Study of Disease Severity and Mortality in Hispanic American Patients With Systemic Sclerosis

    Cohort study

  38. RMD Open

    Prediction of progressive fibrosing interstitial lung disease in patients with systemic sclerosis: insight from the CRDC cohort study

    Diagnostic or prognostic study

  39. Arthritis Res Ther

    Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome

    Cohort study

  40. Rheumatology (Oxford)

    Factors associated with physical function among people with systemic sclerosis: a SPIN cohort cross-sectional study

    Cross-sectional study

All 671 Briefs in ExploreShowing Briefs 401–440 of 671, newest first